BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23868480)

  • 1. Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program.
    Subramanian S; Tangka FK; Hoover S; Beebe MC; DeGroff A; Royalty J; Seeff LC
    Cancer; 2013 Aug; 119 Suppl 15(Suppl 15):2855-62. PubMed ID: 23868480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs.
    Tangka FK; Subramanian S; Beebe MC; Hoover S; Royalty J; Seeff LC
    Cancer; 2013 Aug; 119 Suppl 15(0 15):2863-9. PubMed ID: 23868481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs.
    Subramanian S; Tangka FK; Hoover S; Degroff A; Royalty J; Seeff LC
    Eval Program Plann; 2011 May; 34(2):147-53. PubMed ID: 21036399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental milestones across the programmatic life cycle: implementing the CDC's Colorectal Cancer Screening Demonstration Program.
    Glover-Kudon R; DeGroff A; Rohan EA; Preissle J; Boehm JE
    Cancer; 2013 Aug; 119 Suppl 15(0 15):2926-39. PubMed ID: 23868487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruiting patients into the CDC's Colorectal Cancer Screening Demonstration Program: strategies and challenges across 5 sites.
    Boehm JE; Rohan EA; Preissle J; DeGroff A; Glover-Kudon R
    Cancer; 2013 Aug; 119 Suppl 15(0 15):2914-25. PubMed ID: 23868486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
    Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts.
    Seeff LC; DeGroff A; Joseph DA; Royalty J; Tangka FK; Nadel MR; Plescia M
    Cancer; 2013 Aug; 119 Suppl 15():2940-6. PubMed ID: 23868488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of starting colorectal cancer screening programs: results from five federally funded demonstration programs.
    Tangka FK; Subramanian S; Bapat B; Seeff LC; DeGroff A; Gardner J; Ryerson AB; Nadel M; Royalty J
    Prev Chronic Dis; 2008 Apr; 5(2):A47. PubMed ID: 18341782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening.
    Subramanian S; Tangka FKL; Hoover S; Royalty J; DeGroff A; Joseph D
    Eval Program Plann; 2017 Jun; 62():73-80. PubMed ID: 28190597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC; Rohan EA
    Cancer; 2013 Aug; 119 Suppl 15():2817-9. PubMed ID: 23868475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Program Resources Required for Colonoscopy and Fecal Screening: Findings From 5 Years of the Colorectal Cancer Control Program.
    Subramanian S; Tangka FKL; Hoover S; Cole-Beebe M; Joseph D; DeGroff A
    Prev Chronic Dis; 2019 Apr; 16():E50. PubMed ID: 31022371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing the CDC's Colorectal Cancer Screening Demonstration Program: wisdom from the field.
    Rohan EA; Boehm JE; DeGroff A; Glover-Kudon R; Preissle J
    Cancer; 2013 Aug; 119 Suppl 15(Suppl 15):2870-83. PubMed ID: 23868482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborating across multiple health care institutions in an urban colorectal cancer screening program.
    Villanueva R; Gugel D; Dwyer DM
    Cancer; 2013 Aug; 119 Suppl 15():2905-13. PubMed ID: 23868485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expenditures on Screening Promotion Activities in CDC's Colorectal Cancer Control Program, 2009-2014.
    Tangka FKL; Subramanian S; Hoover S; Cole-Beebe M; DeGroff A; Joseph D; Chattopadhyay S
    Prev Chronic Dis; 2019 Jun; 16():E72. PubMed ID: 31172915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program: a prospective analysis.
    Castro G; Azrak MF; Seeff LC; Royalty J
    Cancer; 2013 Aug; 119 Suppl 15():2849-54. PubMed ID: 23868479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program.
    Nadel MR; Royalty J; Shapiro JA; Joseph D; Seeff LC; Lane DS; Dwyer DM
    Cancer; 2013 Aug; 119 Suppl 15(0 15):2834-41. PubMed ID: 23868477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of promoting cancer screening: Evidence from CDC's Colorectal Cancer Control Program (CRCCP).
    Tangka FKL; Subramanian S; Hoover S; Royalty J; Joseph K; DeGroff A; Joseph D; Chattopadhyay S
    Eval Program Plann; 2017 Jun; 62():67-72. PubMed ID: 27989647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and benefits of an organized fecal immunochemical test-based colorectal cancer screening program in the United States.
    Guy GP; Richardson LC; Pignone MP; Plescia M
    Cancer; 2014 Aug; 120(15):2308-15. PubMed ID: 24737634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a federally funded demonstration colorectal cancer screening program.
    Seeff LC; DeGroff A; Tangka F; Wanliss E; Major A; Nadel M; Ryerson AB; Royalty J; Gelb C; Reed E
    Prev Chronic Dis; 2008 Apr; 5(2):A64. PubMed ID: 18341799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of an Implementation Economics Analysis in Providing the Evidence Base for Increasing Colorectal Cancer Screening.
    Subramanian S; Tangka FKL; Hoover S
    Prev Chronic Dis; 2020 Jun; 17():E46. PubMed ID: 32584756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.